Short-chain fatty acid in the human colon - Relation to inflammatory bowel diseases and colon cancer

被引:0
|
作者
D'Argenio, G [1 ]
Mazzacca, G [1 ]
机构
[1] Univ Naples Federico II, Sch Med, Fac Med & Chirurg,Gastrointestinal Unit, Ist Gastroenterol & Endoscopia, I-80131 Naples, Italy
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Short chain fatty acids (SCFAs) are the end products of anaerobic bacteria break down of carbohydrates in the large bowel. This process, namely fermentation, is an important function of the large bowel; SCFAs, mainly acetate, propionate and butyrate account for approximately 80% of the colonic anion concentration and are produced in nearly constant molar ratio 60:25:15. Among their various properties, SCFAs are readily absorbed by intestinal mucosa, are relatively high in caloric content, are metabolized by colonocytes and epatocytes, stimulate sodium and water absorption in the colon and are trophic to the intestinal mucosa. While the fermentative production of SCFAs has been acknowledged as a principal mechanism of intestinal digestion in ruminants, the interest in the effects of SCFAs production on the human organism has been raising in the last ten years. SCFAs are of major importance in understanding the physiological function of dietary fibers and their possible role in intestinal neoplasia. SCFAs production and absorption are closely related to the nourishment of colonic mucosa, its production from dietary carbohydrates is a mechanism whereby considerable amounts of calories can be produced in short-bowel patients with remaining colonic function and kept on an appropriate dietary regimen. SCFAs enemas or oral probiotics are a new and promising treatment for ulcerative colitis. The effects have been attributed to the oxidation of SCFAs in the colonocytes and to the ability of butyrate to induce enzymes (i.e. transglutaminase) promoting mucosal restitution. Evidence is mounting regarding the effects of butyrate on various cell functions the significance of which needs further considerations. Up until now attention has been related especially to cancer prophylaxis and treatment. This article briefly reviews the role of SCFAs, particularly butyrate, in intestinal mucosal growth and potential clinical applications in inflammatory and neoplastic processes of the large bowel.
引用
收藏
页码:149 / 158
页数:10
相关论文
共 50 条
  • [41] Anti-inflammatory roles of dietary fiber and short-chain fatty acids as regards inflammatory bowel diseases
    Andoh, A
    Fujiyama, Y
    AGRO FOOD INDUSTRY HI-TECH, 2004, 15 (01): : 42 - 43
  • [42] G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer
    Tang, Yong
    Chen, Yakun
    Jiang, Hongmei
    Robbins, Gregory T.
    Nie, Daotai
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (04) : 847 - 856
  • [43] SHORT-CHAIN FATTY-ACID ABSORPTION FROM THE HUMAN DISTAL COLON - INTERACTIONS BETWEEN ACETATE, PROPIONATE AND CALCIUM
    WOLEVER, TMS
    TRINIDAD, TP
    THOMPSON, LU
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1995, 14 (04) : 393 - 398
  • [44] Short-chain fatty acids and colon cancer cells: The vitamin D receptor - Butyrate connection
    Gaschott, T
    Stein, J
    VITAMIN D ANALOGS IN CANCER PREVENTION AND THERAPY, 2003, 164 : 247 - 257
  • [45] Determinants of short-chain fatty acid composition in inflammatory bowel disease: Analysis of the AIM cohort
    Wu, N. B.
    Jenner, A. M.
    Koentgen, S.
    El-Omar, E.
    Hold, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 196 - 198
  • [46] Regulatory role of short-chain fatty acids in inflammatory bowel disease
    Zhilin Zhang
    Huan Zhang
    Tian Chen
    Lin Shi
    Daorong Wang
    Dong Tang
    Cell Communication and Signaling, 20
  • [47] Regulatory role of short-chain fatty acids in inflammatory bowel disease
    Zhang, Zhilin
    Zhang, Huan
    Chen, Tian
    Shi, Lin
    Wang, Daorong
    Tang, Dong
    CELL COMMUNICATION AND SIGNALING, 2022, 20 (01)
  • [48] Peptides, Exopolysaccharides, and Short-Chain Fatty Acids from Fermented Milk and Perspectives on Inflammatory Bowel Diseases
    Rodrigo Sigala-Robles
    Lourdes Santiago-López
    Adrián Hernández-Mendoza
    Belinda Vallejo-Cordoba
    Verónica Mata-Haro
    Abraham Wall-Medrano
    Aarón F. González-Córdova
    Digestive Diseases and Sciences, 2022, 67 : 4654 - 4665
  • [49] The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer
    Lu, Rong
    Wu, Shaoping
    Xia, Yinglin
    Sun, Jun
    CURRENT COLORECTAL CANCER REPORTS, 2012, 8 (01) : 57 - 65
  • [50] IL-23 in inflammatory bowel diseases and colon cancer
    Neurath, Markus F.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2019, 45 : 1 - 8